pemafibrate
Kowa Pharmaceuticals
[' futi', 'vte']
prominent trial showed no benefit for pemafibrate in diabetics with low hdl and elevated tgs. trial was stopped due to futility. there was an increase in vte, though event rate low, and also more renal adverse events. #aha22 
Noninvasive cardiologist keeping up with the latest CV news.